• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News

Our short URL is biophar.ma

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

New Drugs

Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
  • offers treatment for a disease for which no specific therapy previously existed
  • targets a new therapeutic target
  • has a new mechanism of action
  • is developed in a new formulation, optimized or improved
  • is part of a new combination drug
  • belongs to a new class of drug compounds.
Talicia: Highly Effective Eradication Regimen for Helicobacter pylori
Posted inInfections, New Drugs, Oncology, Regulatory

Talicia: Highly Effective Eradication Regimen for Helicobacter pylori

June 5, 2022August 4, 2022

Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

May 17, 2022August 4, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

candida-albicans
Posted inInfections, New Drugs, Regulatory

Vivjoa: First Drug for Chronic Vaginal Yeast Infection

May 1, 2022August 4, 2022

Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.

heart
Posted inMetabolism, New Drugs, Regulatory

Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy

April 29, 2022August 4, 2022

Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.

Tepezza: First Drug for Thyroid Eye Disease
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory

Tepezza: First Drug for Thyroid Eye Disease

April 27, 2022August 4, 2022

Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.

Posts navigation

Newer posts 1 2 3 4 5 … 13 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2022 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News